ARTICLE | Clinical News
Paliperidone palmitate regulatory update
August 15, 2016 7:00 AM UTC
The European Commission approved an MAA from Johnson & Johnson for Trevicta for the maintenance treatment of adults with schizophrenia who are clinically stable on monthly paliperidone palmitate. Trev...